Related references
Note: Only part of the references are listed.Pharmacological characterization of sch527123, a potent allosteric CXCR1/CXCR2 antagonist
Waldemar Gonsiorek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
Richard W. Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists
Jianhua Chao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Comparison of N,N′-diaryisquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor
Brent W. McCleland et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Michael P. Dwyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors
Hong Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect
CS Stevenson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor
Q Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Small molecule interleukin-8 modulators
JJ Li
EXPERT OPINION ON THERAPEUTIC PATENTS (2001)
Share Paper
